InvaGen Pharmaceuticals Plans to Open New Islip, NY, Facility & Create 400 Jobs
01/27/2012
Located in Long Island, NY, InvaGen is a fast-growing generic pharmaceutical company. About 330 workers are employed at its drug product development and commercial operations at three different Hauppauge, NY, facilities.
Construction activity (dependent upon obtaining building permits) could begin as early as February, and will transform one building into a manufacturing, research lab and packaging operation. The firm will invest $20 million in the purchase and renovation part of the project, and $19 million more later in new equipment and research.
Plans call for the revamped facility to be fully operational in five years. The firm anticipates hiring 150 employees within the first two years and paying them an average wage of around $50,000 (according to documents it filed with the Islip Industrial Development Agency).
InvaGen will receive almost $2 million in tax credits through the state's jobs program after meeting job-creation goals, and $3.8 million in tax exemptions over 12 years.
Project Announcements
ValorFlex Packaging Plans Bowling Green, Kentucky, Production Operations
06/30/2025
Neuro.io Plans Terrebonne Parish, Louisiana, Operations
06/30/2025
Germany-Based MTU Maintenance Expands Fort Worth, Texas, MRO Operations
06/30/2025
Cascade Die Casting Group Expands High Point, North Carolina, Manufacturing Operations
06/30/2025
BuildOps Plans Raleigh, North Carolina, Operations
06/30/2025
Point Blank Enterprises Plans Wakulla County, Florida, Operations
06/30/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024